Suppr超能文献

手部挛缩性杜普伊特伦氏病中胶原酶注射与手术筋膜切开术的单中心成本比较分析。

A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.

机构信息

Queen Victoria Hospital, Holtye Road, East Grinstead, West Sussex RH17 3DZ, UK.

Queen Victoria Hospital, Holtye Road, East Grinstead, West Sussex RH17 3DZ, UK.

出版信息

J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):368-72. doi: 10.1016/j.bjps.2013.12.030. Epub 2014 Jan 4.

Abstract

BACKGROUND AND AIM

The options for treating patients with Dupuytren's contracture have broadened with the introduction of collagenase. Although the literature would suggest that collagenase treatment is effective, has few complications and is popular with patients, it has not been widely commissioned by the National Health Services of the United Kingdom and other European countries due to concerns about cost. The aim of this study was to compare the cost of surgical fasciectomy to collagenase injections for the treatment of Dupuytren's contracture in a single centre.

METHOD

Prospective data on 40 patients undergoing fasciectomy or collagenase injection (20 patients in each group) were collected between January and March 2013. Financial data on the costs of the procedures, equipment, theatre time and follow-up appointments were calculated.

RESULTS

The average cost of an open partial fasciectomy pathway was £ 7115.34 and that of a collagenase pathway was £ 2110.62. Eight collagenase patients had physician-led follow-up appointments and only three had hand physiotherapy appointments. By contrast, every fasciectomy patient had at least one physician and one physiotherapist follow-up appointment routinely.

CONCLUSION

The results of this study demonstrate that collagenase treatment for Dupuytren's contracture of a single digit in selected patients is just over £ 5000 less than treatment for the same condition using surgical fasciectomy. Collagenase-treated patients require much less physician- and physiotherapist-led postoperative follow-up.

摘要

背景与目的

随着胶原酶的引入,治疗杜普伊特伦挛缩症患者的选择范围已经扩大。尽管文献表明胶原酶治疗有效,并发症少,且受患者欢迎,但由于对成本的担忧,它并未在英国国民医疗服务体系和其他欧洲国家得到广泛应用。本研究的目的是在单一中心比较外科筋膜切开术和胶原酶注射治疗杜普伊特伦挛缩的成本。

方法

2013 年 1 月至 3 月期间,收集了 40 例接受筋膜切开术或胶原酶注射(每组 20 例)的患者的前瞻性数据。计算了手术、设备、手术室时间和随访预约的费用数据。

结果

开放性部分筋膜切开术的平均费用为 7115.34 英镑,胶原酶治疗的费用为 2110.62 英镑。8 名胶原酶治疗的患者有医生主导的随访预约,只有 3 名患者有手部物理治疗预约。相比之下,每例筋膜切开术患者都有至少一次医生和一次物理治疗师的常规随访预约。

结论

本研究结果表明,在选择的患者中,单一手指的杜普伊特伦挛缩症的胶原酶治疗比手术筋膜切开术治疗的费用少 5000 多英镑。胶原酶治疗的患者需要的医生和物理治疗师主导的术后随访要少得多。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验